By February 20, 2023

a measurable indicator of some biological state or condition. Biomarkers are established at the outset of clinical trials as the physical manifestation of the disease that one seeks to alter as proof that a therapy has been effective. For example, since MLIV patients secrete no stomach acid, one could designate lack of stomach acid as a biomarker if a therapy was intended to change that state.